SPA Pricing Education, Analytics & Decision Making Tools Webinar Series

Tag: Transparent Pricing

Pricing pressure the new worry for Indian pharma | Business Standard News

Pricing pressure the new worry for Indian pharma | Business Standard News

The intense pricing pressure in the US market, reflected in the 26 per cent dip in March 2017 quarter net sales of Sun Pharma’s US subsidiary Taro Pharma, saw India’s largest pharma company lose nearly eight per cent in intra-day trade on Tuesday. The stock closed 4.3 per cent down at Rs 612.55. The price […]

Health care execs are sweating over pricing pressure | Axios

Health care execs are sweating over pricing pressure | Axios

Public outcry over high prices for drugs and health care services has caught the attention of the people who decide those prices. But that doesn’t mean there will be any immediate action. A new survey from investment bank Lazard found that more than half (57%) of 300 U.S. and European health care executives and investors […]

Aviva CEO vows dual pricing solution for ‘dysfunctional’ market | Insurance Times

Aviva CEO vows dual pricing solution for ‘dysfunctional’ market | Insurance Times

Aviva boss Mark Wilson says the insurer is working on a product to solve the insurance problem of dual pricing, a pricing strategy adopted by all insurers which is tearing apart the reputation of the insurance industry. Dual pricing is when new customers are offered cut rate insurance deals, only for the premium to be […]

Aspen faces EU probe over excessive pricing of cancer drugs | BusinessDay

Aspen faces EU probe over excessive pricing of cancer drugs | BusinessDay

Brussels — Aspen Pharmacare faces a EU antitrust investigation for ramping up the price of cancer drugs as the EU joins a global crackdown on the soaring cost of life-saving generic medicines. “When the price of a drug suddenly goes up by several hundred percent, this is something the commission may look at,” EU competition […]

Congress to Trump: Let’s Tackle Drug Pricing in User Fee Reauthorizations | RAPS

Congress to Trump: Let’s Tackle Drug Pricing in User Fee Reauthorizations | RAPS

As part of a bid to bring down the price of pharmaceuticals in the US, Reps. Jan Schakowsky (D-IL), Keith Ellison (D-MN), Rosa DeLauro (D-CT) and 33 other House members sent a letter to President Donald Trump on Monday seeking a way forward to meet the promises he’s made on the campaign trail and since […]

Why Prescription Drugs Cost So Much | AARP

Why Prescription Drugs Cost So Much | AARP

The Ways of Drug Pricing “The simple answer is because there’s nothing stopping them,” says Leigh Purvis, director of health services research for the AARP Public Policy Institute. AARP Membership: Join or Renew for Just $16 a Year Other countries drive a much harder bargain with drug companies. In contrast, the U.S. allows drug companies to pretty […]

WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines | Intellectual Property Watch

WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines | Intellectual Property Watch

The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research […]

Drug pricing didn’t come up in White House biomedical meeting, NIH director says | CNBC

Drug pricing didn’t come up in White House biomedical meeting, NIH director says | CNBC

It was an elephant in the room: Drug pricing has been a key focus of President Donald Trump’s narrative on the drug industry since even before he took office. But in a White House meeting on biomedical research Monday, which included executives from drug companies as well as academic and government health leaders, the topic […]

Was PTC Therapeutics playing games when it tried to defuse the deflazacort controversy with a $35,000 annual price? | ENDPOINTS NEWS

Was PTC Therapeutics playing games when it tried to defuse the deflazacort controversy with a $35,000 annual price? | ENDPOINTS NEWS

When PTC Therapeutics $PTCT CEO Stuart Peltz rolled out the biotech’s Q1 report this morning, he noted that company execs came up with what they believe is a “sustainable” price for the cheap, old steroid acquired from the controversial crew at Marathon Pharmaceuticals for $140 million up front and targeted at the Duchenne community in […]

Sanofi takes its own drug pricing pledge, pointing to a decline in their aggregate net price | ENDPOINTS NEWS

Sanofi takes its own drug pricing pledge, pointing to a decline in their aggregate net price | ENDPOINTS NEWS

What do you do when your industry is routinely pilloried by the president of the US for being run by a group of white collar price gougers, routinely ripping off the American consumer? Brent Saunders speaking at an Endpoints News event on Jan 10, 2017 (Endpoints News) In Big Pharma’s case, you begin to understand […]